09/10/2020
7:29 PM | Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2020
3:00 PM | Deciphera Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2020
4:06 PM | Deciphera Pharmaceuticals (Filer)
| Form 424B5
| |
08/04/2020
3:15 PM | Deciphera Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/06/2020
5:16 PM | Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:00 PM | Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:00 PM | Deciphera Pharmaceuticals (Issuer)
Walsh Dennis Leo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:00 PM | Deciphera Pharmaceuticals (Issuer)
Martin John Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:00 PM | Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:00 PM | Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/12/2020
3:00 PM | Deciphera Pharmaceuticals (Issuer)
Friedman Franklin Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:00 PM | Deciphera Pharmaceuticals (Issuer)
Kelley Susan L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:00 PM | Benz Edward J. JR (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:00 PM | Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2020
4:26 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2020
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2020
3:13 PM | Deciphera Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2020
3:10 PM | Deciphera Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/13/2020
6:47 PM | Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2020
3:10 PM | Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2020
4:49 PM | Deciphera Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/09/2020
3:16 PM | Deciphera Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2020
4:16 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2020
4:10 PM | Deciphera Pharmaceuticals (Filer)
| Form 424B5
| |
01/28/2020
3:13 PM | Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
3:10 PM | Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2020
3:20 PM | Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
| Form 4/A
| |
01/21/2020
3:11 PM | Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2020
3:10 PM | Deciphera Pharmaceuticals (Issuer)
Morl Christopher John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
8:06 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2020
3:10 PM | Deciphera Pharmaceuticals (Issuer)
Morl Christopher John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2019
6:08 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2019
4:00 PM | Deciphera Pharmaceuticals (Issuer)
Morl Christopher John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2019
4:00 PM | Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2019
3:30 PM | Deciphera Pharmaceuticals (Issuer)
Morl Christopher John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2019
3:10 PM | Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2019
3:09 PM | Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2019
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/05/2019
3:20 PM | Deciphera Pharmaceuticals (Issuer)
Morl Christopher John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2019
3:13 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2019
3:45 PM | Deciphera Pharmaceuticals (Issuer)
Friedman Franklin Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2019
7:17 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2019
3:24 PM | Deciphera Pharmaceuticals (Subject)
New Leaf Ventures III, L.P. (Filed by)
| Form SC 13D/A
| |
11/13/2019
3:41 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2019
3:17 PM | Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2019
3:16 PM | Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2019
4:16 PM | Deciphera Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2019
3:02 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2019
4:13 PM | Deciphera Pharmaceuticals (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G
| |
10/17/2019
3:35 PM | Deciphera Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2019
3:21 PM | Deciphera Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/30/2019
8:20 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2019
3:03 PM | Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2019
3:04 PM | Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2019
3:03 PM | Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2019
3:15 PM | Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2019
4:27 PM | Deciphera Pharmaceuticals (Subject)
New Leaf Venture Management III, L.L.C. (Filed by)
| Form SC 13D/A
| |
08/19/2019
3:35 PM | Deciphera Pharmaceuticals (Issuer)
New Leaf Biopharma Opportunities I, L.P. (Reporting)
New Leaf BPO Associates I, L.P. (Reporting)
New Leaf Venture Associates III, L.P. (Reporting)
New Leaf Venture Management III, L.L.C. (Reporting)
New Leaf Ventures III, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2019
4:14 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2019
4:13 PM | Deciphera Pharmaceuticals (Filer)
| Form 424B5
| |
08/14/2019
8:19 PM | Deciphera Pharmaceuticals (Filer)
| Form S-3MEF
| |
08/13/2019
6:57 PM | Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2019
6:55 PM | Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2019
6:52 PM | Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2019
6:51 PM | Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2019
3:18 PM | Deciphera Pharmaceuticals (Filer)
| Form 424B5
| |
08/13/2019
6:12 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2019
6:15 AM | Deciphera Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2019
6:11 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2019
5:31 PM | Deciphera Pharmaceuticals (Issuer)
Kelley Susan L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2019
5:30 PM | Deciphera Pharmaceuticals (Issuer)
Kelley Susan L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2019
3:18 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2019
3:03 PM | Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:33 PM | Deciphera Pharmaceuticals (Issuer)
Ross Michael Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:37 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2019
3:14 PM | Deciphera Pharmaceuticals (Issuer)
Walsh Dennis Leo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:11 PM | Deciphera Pharmaceuticals (Issuer)
Martin John Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:11 PM | Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:10 PM | Benz Edward J. JR (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:10 PM | Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2019
6:12 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2019
3:08 PM | Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2019
3:04 PM | Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2019
3:21 PM | Deciphera Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2019
3:16 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2019
3:08 PM | Deciphera Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/22/2019
3:06 PM | Deciphera Pharmaceuticals (Filer)
| Form DEF 14A
| |
03/20/2019
4:49 PM | Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2019
4:47 PM | Deciphera Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
3:15 PM | Deciphera Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/14/2019
3:12 PM | Deciphera Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2019
3:09 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2019
3:30 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2019
7:37 PM | Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
6:25 PM | Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
6:24 PM | Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2019
3:09 PM | Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2019
3:04 PM | Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2019
3:21 PM | Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
